N-stearoylethanolamine restores pancreas lipid composition in obesity-induced insulin resistant rats

Lipids

Volumn 50, Issue 1, 2014, Pages 13-21

  Onopchenko, Oleksandra V ^a,c   Kosiakova, Galina V ^a   Oz, Murat ^b   Klimashevsky, Vitaliy M ^a   Gula, Nadiya M ^a  

^a INSTITUTE OF HYDROBIOLOGY   (Ukraine)

^b UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^c NONE   (Ukraine)

Author keywords

Cholesterol; Experimental insulin resistance; Fatty acid; N Stearoylethanolamine; Obesity; Pancreas; Phospholipid; Triglyceride

Indexed keywords

CHOLESTEROL; FATTY ACID; GLYCEROPHOSPHOLIPID; INSULIN; LIPID; N STEAROYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLSERINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; ETHANOLAMINE DERIVATIVE; N-STEAROYLETHANOLAMINE; STEARIC ACID DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GAS LIQUID CHROMATOGRAPHY; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIPID COMPOSITION; LIPID DIET; MALE; NONHUMAN; PANCREAS; RAT; THIN LAYER CHROMATOGRAPHY; TRIACYLGLYCEROL BLOOD LEVEL; ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMISTRY; COMPLICATION; DRUG EFFECTS; LIPID METABOLISM; METABOLISM; OBESITY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; DIET, HIGH-FAT; ETHANOLAMINES; INSULIN; INSULIN RESISTANCE; LIPID METABOLISM; LIPIDS; MALE; OBESITY; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; STEARIC ACIDS;

EID: 84920479471     PISSN: 00244201     EISSN: 15589307     Source Type: Journal    
DOI: 10.1007/s11745-014-3960-1     Document Type: Article

References (38)

1. World health organization (2014) Obesity and overweight. Fact sheet No 311, Accessed Apr 2014 http://www.who.int/mediacentre/factsheets/fs311/en/
2. Szczepaniak LS, Victor RG, Mathur R, Nelson MD, Szczepaniak EW, Tyer N, Chen I, Unger RH, Bergman RN, Lingvay I (2012) Pancreatic steatosis and its relationship to β-cell dysfunction in humans: racial and ethnic variations. Diabetes Care 35:2377-2383
3. Matias I, Gonthier MP, Petrosino S, Docimo L, Capasso R, Hoareau L, Monteleone P, Roche R, Izzo AA, Di Marzo V (2007) Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br J Pharmacol 152:676-690
4. Lambert DM, Muccioli GG (2007) Endocannabinoids and related N-acylethanolamines in the control of appetite and energy metabolism: emergence of new molecular players. Curr Opin Clin Nutr Metab Care 10:735-744
5. Artmann A, Petersen G, Hellgren LI, Boberg J, Skonberg C, Nellemann C, Hansen SH, Hansen HS (2008) Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 1781:200-212
6. Ansarullah LuY, Holstein M, DeRuyter B, Rabinovitch A, Guo Z (2013) Stimulating β-Cell regeneration by combining a GPR119 agonist with a DPP-IV inhibitor. PLoS ONE 8:e53345
7. Sharma AK, Bharti S, Kumar R, Krishnamurthy B, Bhatia J, Kumari S, Arya DS (2012) Ameliorates insulin resistance and β-cell dysfunction via modulation of PPARγ, dyslipidemia, oxidative stress, and TNF-α in Type 2 diabetic rats. J Pharmacol Sci 119:205-213
8. Hula NM, Chumak AA, Berdyshev AH, Mehed' OF, Horid'ko TM, Kindruk NL, Kosiakova HV, Zhukov OD (2009) Anti-inflammatory effect of N-stearoylethanolamine in experimental burn injury in rats. Ukr Biokhim Zh 81:107-116
9. Gorid'ko TM, Kosiakova HV, Berdyshev AH, Bazylians'ka VR, Margitych VM, Gula NM (2012) The influence of N-stearoylethanolamine on the activity of antioxidant enzymes and on the level of stable NO metabolites in the rat testes and blood plasma at the early stages of streptozotocine-induced diabetes. Ukr Biokhim Zh 84:37-43
10. Kosiakova HV, Hula NM (2007) The N-stearoylethanolamine effect on the NO-synthase way of nitrogen oxide formation and phospholipid composition of erythrocyte membranes in rats with streptozotocine diabetes. Ukr Biokhim Zh 79:53-59
11. Horid'ko TM, Hula NM, Stohni NA, Mehed' OF, Klimashevs'ky VM, Shovkun SA, Kindruk NL, Berdyshev AH (2007) Effect of N-stearoylethanolamine on the lipid peroxidation process and lipid composition of the rat liver in acute morphine intoxication. Ukr Biokhim Zh 79:175-185
12. Onopchenko OV, Kosiakova GV, Horid'ko TM, Klimashevsky VM, Hula NM (2014) The effect of N-stearoylethanolamine on liver phospholipid composition of rats with high-fat diet-induced insulin resistance. Ukr Biokhim Zh 86:101-110
13. Svegliati-Baroni G, Candelaresi C, Saccomanno S, Ferretti G, Bachetti T, Marzioni M, De Minicis S, Nobili L, Salzano R, Omenetti A, Pacetti D, Sigmund S, Benedetti A, Casini A (2006) A model of insulin resistance and nonalcoholic steatohepatitis in rats: role of peroxisome proliferator-activated receptor-alpha and n-3 polyunsaturated fatty acid treatment on liver injury. Am J Pathol 169:846-860
14. Onopchenko OV, Kosiakova HV, Horid'ko TM, Berdyshev AH, Mehed' OF, Hula NM (2013) The effect of N-stearoylethanolamine on the activity of antioxidant enzymes, content of lipid peroxidation products and nitric oxide in the blood plasma and liver of rats with induced insulin-resistance. Ukr Biokhim Zh 85:88-96
15. Epps DE, Natarajan V, Schmid PC, Schmid HO (1980) Accumulation of N-acylethanolamine glycerophospholipids in infarcted myocardium. Biochim Biophys Acta 618:420-430
16. Artamonov M, Zhukov O, Shuba I, Storozhuk L, Khmel T, Klimashevsky V, Mikosha A, Gula N (2005) Incorporation of labelled N-acylethanolamine (NAE) into rat brain regions in vivo and adaptive properties of saturated NAE under x-ray irradiation. Ukr Biokhim Zh 77:51-62
17. Dalle Carbonare M, Del Giudice E, Stecca A, Colavito D, Fabris M, D'Arrigo A, Bernardini D, Dam M, Leon A (2008) A saturated N-acylethanolamine other than N-palmitoyl ethanolamine with anti-inflammatory properties: a neglected story. J Neuroendocrinol Suppl 1:26-34. doi: 10.1111/j.1365-2826.2008.01689.x
18. Bligh EG, Dyer WI (1959) A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
19. Vaskovsky VE, Kostetsky EY, Vasendin IM (1975) A universal reagent for phospholipid analysis. J Chromatogr 114:129-141
20. Vaskovsky VE, Terekhova TA (1979) HPTLC of phospholipid mixtures containing phosphatidylglycerol. J High Resol Chromatogr 2:671-672
21. Svetashev VI, Vaskovsky VE (1972) A simplified technique for thin-layer microchromatography of lipids. J Chromatogr 67:376-378
22. Ichihara K, Fukubayashi Y (2010) Preparation of fatty acid methyl esters for gas-liquid chromatography. J Lipid Res 51:635-640
23. McLauren Dorrance A, Graham D, Dominiczak A, Fraser R (2000) Inhibition of nitric oxide synthesis increases erythrocyte membrane fluidity and unsaturated fatty acid content. Am J Hypertens 13:1194-1202
24. Cedernaes J, Alsiö J, Västermark A, Risérus U, Schiöth HB (2013) Adipose tissue stearoyl-CoA desaturase 1 index is increased and linoleic acid is decreased in obesity-prone rats fed a high-fat diet. Lipids Health Dis 12:2. doi: 10.1186/1476-511X-12-2
25. Anderson N, Borlak J (2008) Molecular mechanisms and therapeutic targets in steatosis and steatohepatitis. Pharmacol Rev 60:311-357
26. Parpal S, Karlsson M, Thorn H, Strålfors P (2001) Cholesterol depletion disrupts caveolae and insulin receptor signaling for metabolic control via insulin receptor substrate-1, but not for mitogen-activated protein kinase control. J Biol Chem 276:9670-9678
27. Calder PC, Yaqoob P (2007) Lipid rafts-composition, characterization, and controversies. J Nutr 137:545-547
28. Leibiger IB, Leibiger B, Berggren PO (2008) Insulin signaling in the pancreatic β-cell. Annu Rev Nutr 28:233-251
29. Persaud SJ, Asare-Anane H, Jones PM (2002) Insulin receptor activation inhibits insulin secretion from human islets of Langerhans. FEBS Lett 510:225-228
30. Hula NM, Kosiakova HV, Kindruk NL, Khmel' TO (2005) Effect of N-stearoylethanolamine on the level of stable NO metabolites in different pathological conditions which are accompanied by oxidative stress. Ukr Biokhim Zh 77:113-119
31. Nakamura MT, Nara TY (2004) Structure, function, and dietary regulation of 6, 5, and 9 desaturases. Annu Rev Nutr 24:345-376
32. Brown JM, Rudel LL (2010) Stearoyl-coenzyme A desaturase 1 inhibition and the metabolic syndrome: considerations for future drug discovery. Curr Opin Lipidol 21:192-197
33. Ollila S, Hyvönen MT, Vattulainen I (2007) Polyunsaturation in lipid membranes: dynamic properties and lateral pressure profiles. J Phys Chem B 111:3139-3150
34. Elmendorf JS (2004) Fluidity of insulin action. Mol Biotechnol 27:127-138
35. Hardwick JP, Eckman K, Lee YK, Abdelmegeed MA, Esterle A, Chilian WM, Chiang JY, Song BJ (2013) Eicosanoids in metabolic syndrome. Adv Pharmacol 66:157-266
36. Chen M, Yang ZD, Smith KM, Carter JD, Nadler JL (2005) Activation of 12-lipoxygenase in proinflammatory cytokine-mediated beta cell toxicity. Diabetologia 48:486-495
37. Høstmark AT, Haug A (2013) Percentages of oleic acid and arachidonic acid are inversely related in phospholipids of human sera. Lipids Health Dis 12:106
38. Gulaya NM, Kuzmenko AI, Margitich VM, Govseeva NM, Melnichuk SD, Goridko TM, Zhukov AD (1998) Long-chain N-acylethanolamines inhibit lipid peroxidation in rat liver mitochondria under acute hypoxic hypoxia. Chem Phys Lipids 97:49-54